Lv12
60 积分 2023-09-19 加入
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases
18小时前
待确认
Glucagon acts in the liver to control spontaneous meal size in rats
18小时前
已完结
Dose-related suppression of feeding by intraportal glucagon infusion in the rat
18小时前
已完结
Review Article: GLP-1 Receptor Agonists and Glucagon/GIP/GLP-1 Receptor Dual or Triple Agonists-Mechanism of Action and Emerging Therapeutic Landscape in MASLD
18小时前
待确认
The renal glucagon receptor is essential to kidney metabolic and homeostatic functions
19小时前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990-2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
1天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
11天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
12天前
已完结
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update
18天前
已完结
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
19天前
已完结
皖公网安备34019202002308
